Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Our New Resource Page for Sclerosing Cholangiocarcinoma of the Biliary Tract

Sclerosing cholangiocarcinoma of the biliary tract is the most common type of bile duct cancer in patients who have primary sclerosing cholangitis. It is a deadly cancer of the bile duct occurring in 2-8% of patients and is the leading cause of death among them. Most...

Our New Resource Page for Malignant Fibrous Histiosarcoma

Malignant Fibrous Histiosarcoma is a rare type of soft tissue cancer caused by uncontrolled cell division in the mesenchyme. It predominantly develops in males older than 60 years of age.  It commonly affects the arms and legs but can develop anywhere in the body....

Our New Resource Page for Papillary Endometrioid Carcinoma

Papillary endometrioid carcinoma is a tumor that originates from the endometrial layer of the uterus. It has a papillary structure and is characterized by the presence of a fibrovascular bundle. This type of tumor is dependent on estrogen and generally has a favorable...

Our New Resource Page for Malignant External Rhabdoid Tumour

Malignant external rhabdoid tumour (MERT) is a rare and highly aggressive childhood cancer that primarily affects the kidneys, but it can also arise in other parts of the body, such as soft tissues, muscles, tendons, connective tissues, and the brain. When these...

Our New Resource Page for Leydig Cell Tumour of the Ovary

Leydig cell tumours also known as Sertoli-Leydig cell tumour (SLCT), is extremely rare, accounting for less than 0.5% of all ovarian cancers. Although they can occur at any age, they are most common in women who are approaching menopause. Many sufferers of Leydig Cell...
Older Entries
Next Entries

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter